Literature DB >> 30801389

Two-surgeon Model in Laparoscopic Pancreaticoduodenectomy.

Yunqiang Cai1,2, Sirui Chen3, Bing Peng2.   

Abstract

PURPOSE: Laparoscopic pancreaticoduodenectomy (LPD) is one of the most challenging gastrointestinal surgeries. Herein, we propose a new laparoscopic surgical conception called the 2-surgeon model and share our experience in LPD.
MATERIALS AND METHODS: We began performing LPD using the 2-surgeon model in October 2015. To December 2017, we have performed 203 cases of LPDs using 2-surgeon model. Data associated with demographic characteristics, operative outcomes, and postoperative results were prospectively collected and analyzed retrospectively.
RESULTS: Only 1 patient in our series required to conversion to open surgery. The mean operative time was 318 minute. The estimated blood loss was 108 mL. The overall complication was 26.1%. In total, 41 patients (20.2%) suffered from pancreatic fistula, including 33 cases of grade A, 7 cases of grade B, and 1 case of grade C. The 90-day mortality was 0.5%.
CONCLUSIONS: The 2-surgeon model is safe and feasible for LPD.

Entities:  

Mesh:

Year:  2019        PMID: 30801389     DOI: 10.1097/SLE.0000000000000649

Source DB:  PubMed          Journal:  Surg Laparosc Endosc Percutan Tech        ISSN: 1530-4515            Impact factor:   1.719


  2 in total

Review 1.  International expert consensus on laparoscopic pancreaticoduodenectomy.

Authors:  Renyi Qin; Michael L Kendrick; Christopher L Wolfgang; Barish H Edil; Chinnusamy Palanivelu; Rowan W Parks; Yinmo Yang; Jin He; Taiping Zhang; Yiping Mou; Xianjun Yu; Bing Peng; Palanisamy Senthilnathan; Ho-Seong Han; Jae Hoon Lee; Michiaki Unno; Steven W M Olde Damink; Virinder Kumar Bansal; Pierce Chow; Tan To Cheung; Nim Choi; Yu-Wen Tien; Chengfeng Wang; Manson Fok; Xiujun Cai; Shengquan Zou; Shuyou Peng; Yupei Zhao
Journal:  Hepatobiliary Surg Nutr       Date:  2020-08       Impact factor: 7.293

2.  Laparoscopic pancreatectomy for benign or low-grade malignant pancreatic tumors: outcomes in a single high-volume institution.

Authors:  He Cai; Lu Feng; Bing Peng
Journal:  BMC Surg       Date:  2021-12-07       Impact factor: 2.102

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.